Kava for Anxiety: Evidence, Benefits, and Liver Safety Concerns
This conversation explores the scientific evidence supporting kava for anxiety, including findings from a 2022 review and broader clinical trials. It covers kava's anxiolytic effects, mechanisms via GABA receptors, and important safety considerations like liver toxicity risk and quality of preparations.
Does kava actually help with anxiety, and what does the research say?
Kava for Anxiety: What the Research Says
Yes, there is scientific evidence supporting the use of kava (Piper methysticum) for reducing anxiety. Here's a breakdown of what the research shows:
Evidence from Pillser's Research Database
Pillser's research database contains 1 study on kava for anxiety, which is a 2022 review titled "Nip it in the Bud: Botanicals for Anxiety – a Practical Prescriber's Guide"1. The data shows:
- 1 study — Beneficial effect (moderate, statistically significant)
- 0 studies — Neutral or inconclusive results
- 0 studies — Harmful effects
The review concluded that there is scientific evidence supporting the use of kava (alongside lavender, lemon balm, and passionflower) in anxiety disorders1.
Broader Context
Beyond this single review, kava has been studied more extensively in the broader literature:
- Multiple clinical trials have shown that kava extracts (standardized to kavalactones) can significantly reduce symptoms of generalized anxiety disorder (GAD) compared to placebo.
- Some studies have found kava to be comparably effective to low-dose benzodiazepines for mild-to-moderate anxiety, but with a lower risk of dependency.
- The active compounds — kavalactones (kavain, dihydrokavain, methysticin, etc.) — are believed to work by modulating GABA receptors and sodium channels, producing a calming effect.
Important Safety Considerations
Despite its potential benefits, kava comes with some important caveats:
- Liver toxicity — There have been reports of hepatotoxicity (liver damage) associated with kava use, particularly with extracts made from the aerial parts (stems and leaves) rather than the traditional rhizome (root). Many countries (including the UK, Canada, and parts of Europe) have restricted or banned kava due to these concerns.
- Quality matters — The risk of liver issues is thought to be higher with poor-quality or non-traditional preparations. Using only noble kava root extracts from reputable sources is advised.
- Dosing — Typical doses in clinical trials ranged from 120–280 mg of kavalactones per day, divided into multiple doses.
Bottom Line
Kava shows promise as an anxiolytic (anxiety-reducing) supplement with supporting evidence from research. However, the liver safety concerns are a significant consideration that should not be overlooked. It's always recommended to consult with a healthcare professional before starting kava, especially if you have existing liver conditions, take medications, or consume alcohol regularly.
Footnotes
-
Pillser research database, Kava and Reduced Anxiety. ↩ ↩2